Rameen Beroukhim mostly deals with Cancer research, Cancer, Genetics, Gene and Somatic cell. His Cancer research research is multidisciplinary, incorporating elements of DNA methylation, KRAS, Gefitinib, PTEN and Adenocarcinoma. His Cancer study combines topics in areas such as Gene dosage, Human genome, Gene duplication and Point mutation.
His Computational biology research extends to Genetics, which is thematically connected. His work carried out in the field of Exome brings together such families of science as Chromophobe cell, Chromophobe Renal Cell Carcinoma, Targeted therapy, Breast cancer and Genetic heterogeneity. The concepts of his Breast cancer study are interwoven with issues in Exome sequencing and MicroRNA sequencing.
Rameen Beroukhim mainly focuses on Cancer research, Cancer, Genetics, Gene and Genome. His study looks at the intersection of Cancer research and topics like Carcinogenesis with Molecular biology. His studies deal with areas such as Gene duplication, Gene dosage and Aneuploidy as well as Cancer.
His Genetics study is mostly concerned with Somatic cell, Loss of heterozygosity, Human genome, SNP array and Human genetics. His Genome instability research extends to the thematically linked field of Gene. His study looks at the relationship between Genome and topics such as Computational biology, which overlap with Genomics.
His main research concerns Cancer research, Genome, Computational biology, Glioma and Cancer. His Cancer research research incorporates elements of Phenotype, Cell cycle, Oncogene and Protein overexpression. His biological study spans a wide range of topics, including Somatic cell, Genome instability and Human genetics.
Somatic cell is a subfield of Genetics that Rameen Beroukhim explores. His Computational biology research is multidisciplinary, relying on both Cell, Gene, CRISPR, Genomics and Chromothripsis. Rameen Beroukhim combines subjects such as Mutation and DNA damage with his study of Cancer.
The scientist’s investigation covers issues in Cancer research, Genome, Computational biology, Cancer and Gene. His research in Cancer research intersects with topics in Aneuploidy and Renal medullary carcinoma. His study in Genome is interdisciplinary in nature, drawing from both Human genetics and Somatic cell.
His study with Somatic cell involves better knowledge in Genetics. His Computational biology research incorporates themes from Chromothripsis, Genome instability, Cancer type and Germline mutation. The various areas that Rameen Beroukhim examines in his Cancer study include Apoptosis and Reprogramming.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt;Robert S. Fulton;Michael D. McLellan;Heather Schmidt.
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Roger McLendon;Allan Friedman;Darrell Bigner;Erwin G. Van Meir.
The cancer genome atlas pan-cancer analysis project
John N Weinstein;John N Weinstein;Eric A. Collisson;Gordon B Mills;Kenna R Mills Shaw;Kenna R Mills Shaw.
Nature Genetics (2013)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny;Matthew N. Bainbridge;Kyle Chang;Huyen H. Dinh.
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan;Roel G W Verhaak;Aaron McKenna;Benito Campos.
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass;Vesteinn Thorsson;Ilya Shmulevich;Sheila M. Reynolds.
Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network
Eric A. Collisson;Joshua D. Campbell;Angela N. Brooks;Angela N. Brooks;Alice H. Berger.
Comprehensive molecular characterization of urothelial bladder carcinoma
John N Weinstein;Rehan Akbani;Bradley McIntosh Broom;Wenyi Wang.
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim;Craig H. Mermel;Craig H. Mermel;Dale Porter;Guo Wei.
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton;Margaret Morgan;Preethi H. Gunaratne;Preethi H. Gunaratne;David A. Wheeler.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: